학술논문
Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study
Document Type
Article
Author
Source
In Annals of Oncology July 2020 31(7):942-950
Subject
Language
ISSN
0923-7534